Please consult the UK government website.
For details of the scope of the regulation please check: FMD Delegated Regulation 2016_161
Where stakeholders are unclear on the legislation, for example whether types of medicine are in/out of scope, please contact DHSC/MHRA at fmd. safetyfeatures@mhra. gov. uk.
The MHRA has confirmed that subject to the outcome of a public consultation anti-tamper devices may continue to be placed on out-of-scope products after 9th February 2019 if the relevant manufacturer considers that it is necessary to do so in the interests of patient safety.
What is the FMD?
Since 9th February 2019, the Falsified Medicines Directive (FMD) and associated Delegated Regulation (DR) have imposed new regulatory obligations on all organisations that manufacture and/or dispense prescription-only medicines (POMs)*.
For more information, please visit the NHS Digital FMD Toolkit for Community Pharmacy. FMD Source, the website of the UK FMD Working Group for Community Pharmacy, is also a useful guide. Community Pharmacy Northern Ireland (CPNI) also have some useful information.
We use cookies to give you a better experience. By continuing to use our site, you are agreeing to the use of cookies as set in our Cookie Policy.
Accept all cookies Manage cookie settings